Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.

The global sleep apnea implants market is projected to expand at a compound annual growth rate (CAGR) of approximately 10% ...

It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

Assessing mean apnea-hypopnea duration (MAD) in patients with OSA yields hypoxemia and symptom burden data not provided by the AHI or ODI.

KBIA’s Rebecca Smith recently sat down with Dr. Mohammad Badran at the University of Missouri who studies sleep apnea to ...

Obstructive sleep apnea, a condition that causes lower oxygen levels during sleep, is linked to degeneration of brain regions associated with memory through damage to the brain's small blood vessels, ...

Experts reveal symptoms that strike during nighttime rest and what those signs might mean for your health.

Many people think that snoring is just a normal part of sleep. But for some, it can be a sign of a serious and often ignored ...

Medical News Today looks at three key studies and their key findings that highlight and further confirm the connection between how poor sleep increases dementia risk.